期刊文献+

氟伐他丁对ACS患者CRP及sICAM-1、sVCAM-1的影响

Effect of Fluvastatin on Serum CRP, SLCAM-1 and SVCAM-1 Contents in Patients with Acute Coronary Syndrome
下载PDF
导出
摘要 Objective To study the effect of fluvastatin on changes of serum C-reactive protein(CRP) and soluable intercellular adhesion molecule-1(sICAM-1),soluabe vas-cular cell adhesion molecule-1(sVCAM-1) contents in patients with acute coronary syndrome(ACS). Methods 109 patients with ACS were randomly divided into fluvastatin-treated group(55 cases) and conventional therapy group (54 cases). The contents of serum CRP (with immunoturbidity method), sICAM-1,sVCAM-1 (with ELISA) were measured both before and after treatment for 8 weeks with fluvastat in in these cardiac patients as well as in 50 controls. Results ① Befor treatment, the levels of serum CRP, sICAM-1, sVCAM-1 were significantly higher in the patients with ACS than controls(P<0.01). ②After treatment,the levels of serum CRP, sICAM-1,sVCAM-1 in patients with fluvastatin decreased significantly(P<0.01), but the levels were not much changed in the conventional therapy group. Conclusion Fluvastatin can decrease inflammation and cell adhesion in patients with ACS . Objective To study the effect of fluvastatin on changes of serum C - reactive protein(CRP) and soluable intercellular adhesion molecule - 1 ( sICAM - 1 ), soluabe vas - cular cell adhesion molecule - 1 ( sVCAM - 1 ) contents in patients with acute coronary syndrome(ACS). Methods 109 patients with ACS were randomly divided into fluvastatin - treated group(55 cases) and conventional therapy group (54 cases ). The contents of serum CRP ( with immunoturbidity method), sICAM - 1, sVCAM - 1 (with ELISA) were measured both before and after treatment for 8 weeks with fluvastat in in these cardiac patients as well as in 50 controls. Results ① Befor treatment, the levels of serum CRP, sICAM - 1, sVCAM - 1 were significantly higher in the patients with ACS than controls(P 〈0.01 ). ②After treatment,the levels of serum CRP, sICAM - 1 ,sVCAM - 1 in patients with fluvastatin decreased significantly(P 〈0.01), but the levels were not much changed in the conventional therapy group. Conclusion Fluvastatin can decrease inflammation and cell adhesion in patients with ACS .
出处 《放射免疫学杂志》 CAS 2007年第3期280-281,共2页 Journal of Radioimmanology
基金 连云港市125工程医学重点人才资助项目
关键词 急性冠状动脉综合征 氟伐他丁 C-反应蛋白 细胞黏附分子 acute coronary syndrome, Fluvastatin, C - reactive protein, cell adhesion molecules
  • 相关文献

参考文献6

  • 1Goran K,Hansson.Immune mechanism in atherosclerosis.Arteroscler Thromb Vasc Biol.2001,21:1876.
  • 2杨胜利,何秉贤,何学兰,张伟,杨春荣.C-反应蛋白是急性冠状动脉综合征的一种危险因子[J].中华心血管病杂志,2002,30(10):618-619. 被引量:122
  • 3Mazzone A,Serri S D,Ricevuti G,et al.Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease.Circulation.1993,88(2):358.
  • 4Filippo C,Luigi MB,Antonino B,et al.Role of inflammation in the pathogenesis of unstable coronary artery disease.Am J Cardiol.1997,80(5A):10.
  • 5周同,宋长玲.细胞粘附分子与心血管疾病[J].中国循环杂志,1995,10(8):502-504. 被引量:16
  • 6Heart protection study collaborative Group.MRC/BHF Heart protection study of cholesterol lowering with simvastatin in 20536 high-risk individuals:a randomized placebo-controlled trial.Lancet.2002:360:7.

二级参考文献1

共引文献136

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部